# Anxiety & Depression

Created by:

> - Travis Gerrard, MD, General Internist

Contact us:

> <htnfyi@gmail.com>

# Support

For any support inquiries, please contact us at:

> <htnfyi@gmail.com>

# References

This application is based on current evidence-based clinical guidelines and research for anxiety and depression. Key references include:

## Clinical Practice Guidelines

1. **National Institute for Health and Care Excellence (NICE).** Depression in adults: treatment and management. *NICE guideline [NG222]*. 2022 (updated 2024). [View guideline](https://www.nice.org.uk/guidance/ng222)

2. **VA/DoD Clinical Practice Guideline Working Group.** VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder. Version 4.0. 2022. [View guideline](https://www.healthquality.va.gov/guidelines/mh/mdd/)

3. **American Psychological Association.** Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts. 2019. [View guideline](https://www.apa.org/depression-guideline)

4. **National Institute for Health and Care Excellence (NICE).** Generalised anxiety disorder and panic disorder in adults: management. *NICE guideline [CG113]*. 2011 (updated 2020). [View guideline](https://www.nice.org.uk/guidance/cg113)

## Screening and Assessment

5. **US Preventive Services Task Force.** Screening for Depression and Suicide Risk in Adults. *JAMA*. 2023;329(23):2057-2067. [doi:10.1001/jama.2023.9297](https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-adults)

6. **Kroenke K, Spitzer RL, Williams JB.** The PHQ-9: validity of a brief depression severity measure. *J Gen Intern Med*. 2001;16(9):606-13. [PMID: 11556941](https://pubmed.ncbi.nlm.nih.gov/11556941/)

7. **Spitzer RL, Kroenke K, Williams JB, Löwe B.** A brief measure for assessing generalized anxiety disorder: the GAD-7. *Arch Intern Med*. 2006;166(10):1092-7. [PMID: 16717171](https://pubmed.ncbi.nlm.nih.gov/16717171/)

## Medication Treatment

8. **Cipriani A, Furukawa TA, Salanti G, et al.** Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. *Lancet*. 2018;391(10128):1357-1366. [doi:10.1016/S0140-6736(17)32802-7](https://www.thelancet.com/article/S0140-6736(17)32802-7/fulltext)

9. **Jakubovski E, Varigonda AL, Freemantle N, Taylor MJ, Bloch MH.** Systematic Review and Meta-Analysis: Dose-Response Relationship of Selective Serotonin Reuptake Inhibitors in Major Depressive Disorder. *Am J Psychiatry*. 2016;173(2):174-83. [PMID: 26552940](https://pubmed.ncbi.nlm.nih.gov/26552940/)

10. **Jakubovski E, Johnson JA, Nasir M, Müller-Vahl K, Bloch MH.** Systematic review and meta-analysis: Dose-response curve of SSRIs and SNRIs in anxiety disorders. *Depress Anxiety*. 2019;36(3):198-212. [PMID: 30479005](https://pubmed.ncbi.nlm.nih.gov/30479005/)

11. **Guaiana G, Barbui C, Meader N.** Antidepressants versus placebo for generalized anxiety disorder (GAD). *Cochrane Database Syst Rev*. 2025. [PMID: 39880377](https://pubmed.ncbi.nlm.nih.gov/39880377/)

## Medication Safety

12. **US Food and Drug Administration.** Suicidality in Children and Adolescents Being Treated With Antidepressant Medications. FDA Safety Communication. [View communication](https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/suicidality-children-and-adolescents-being-treated-antidepressant-medications)

13. **Friedman RA, Leon AC.** Expanding the Black Box — Depression, Antidepressants, and the Risk of Suicide. *N Engl J Med*. 2007;356:2343-2346. [doi:10.1056/NEJMp078015](https://www.nejm.org/doi/full/10.1056/NEJMp078015)

14. **American Geriatrics Society 2023 Beers Criteria® Update Expert Panel.** American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. *J Am Geriatr Soc*. 2023;71(7):2052-2081. [doi:10.1111/jgs.18372](https://agsjournals.onlinelibrary.wiley.com/doi/10.1111/jgs.18372)

## Exercise and Physical Activity

15. **Noetel M, Sanders T, Gallardo-Gómez D, et al.** Effect of exercise for depression: systematic review and network meta-analysis of randomised controlled trials. *BMJ*. 2024;384:e075847. [doi:10.1136/bmj-2023-075847](https://pmc.ncbi.nlm.nih.gov/articles/PMC10870815/)

## Decision Aids

16. **Coulter A, Stilwell D, Kryworuchko J, Mullen PD, Ng CJ, van der Weijden T.** A systematic development process for patient decision aids. *BMC Med Inform Decis Mak*. 2013;13 Suppl 2:S2. [doi:10.1186/1472-6947-13-S2-S2](https://bmcmedinformdecismak.biomedcentral.com/articles/10.1186/1472-6947-13-S2-S1)

17. **Elwyn G, O'Connor AM, Bennett C, et al.** Assessing the quality of decision support technologies using the International Patient Decision Aid Standards instrument (IPDASi). *PLoS One*. 2009;4(3):e4705. [doi:10.1371/journal.pone.0004705](https://pmc.ncbi.nlm.nih.gov/articles/PMC8474333/)

18. **Hoffman AS, Bateman S, Housten AJ, et al.** SUNDAE Checklist for Reporting Decision Aid Development Studies. *BMJ Qual Saf*. 2018;27(5):380-388. [doi:10.1136/bmjqs-2017-006986](https://qualitysafety.bmj.com/content/27/5/380)

## Crisis Resources

19. **988 Suicide & Crisis Lifeline.** National crisis support service available 24/7 via call, text, or chat. [988lifeline.org](https://988lifeline.org/)

---

**Disclaimer**: This information is for educational purposes only and does not replace professional medical advice. If you are experiencing a mental health crisis or thoughts of self-harm, please call 988 or go to your nearest emergency department.
